Fabtech Technologies Ltd Share Price

Fabtech Technologies Limited was incorporated as a Private Company under the name and style of Globeroute Ventures Private Limited dated October 26 2018 issued by the Registrar of Companies Central Registration Centre. Subsequently Company name was changed to Fabtech Technologies Private Limited and a fresh Certificate of Incorporation dated January 21 2021 was issued by the Registrar of Companies Mumbai. Further the status converted into a Public Company to which the Company was renamed to Fabtech Technologies Limited and a fresh Certificate of Incorporation on July 24 2024 was issued by the Registrar of Companies Central Processing Centre.The Company is a key turnkey engineering solution provider in pharmaceuticals capex space offering comprehensive start to finish solutions encompassing designing engineering procurement installation and testing of pharmaceutical equipment for a wide range of customers. In 2020 the Export Division of Fabtech Technologies International Private Limited FTIPL under which it executed turnkey pharmaceutical engineering projects was demerged into the Company through Scheme of Amalgamation. Further the entire shareholding also got transferred from FTIPL to shareholders of FTIPL by virtue of which Aasif Ahsan Khan Hemant Mohan Anavkar Aarif Ahsan Khan and Manisha Hemant Anavkar became the Promoters of the Company in 2020. The Company completed a a turnkey project for a stateowned organization in Bangladesh involving installation of 172 clean room doors across designated buildings in 2022. It completed installation of process equipment such as isolators tablet compression equipment and related infrastructure for a pharmaceutical manufacturer in Algeria in 2023. Further completed procurement implementation of facilities and monitoring of cleanrooms installation work for a facility to manufacture oral solid dosage liquid oral dosage disinfectant and penicillin secondary packaging area in Kingdom of Saudi Arabia.In 2024 the Company acquired FT Institutions Private Limited from FTIPL by executing turnkey pharmaceutical engineering projects in India. To create a local presence in the Middle Eastern region it set up a whollyowned subsidiary Fabtech Technologies LLC and a stepdown subsidiary FTS Cleanrooms Systems LLC in Sharjah UAE. The Company in 2024 has acquired FABL International Technologies LLP from FTIPL to consolidate its operations by developing manufacturing capabilities in oral solid dosage process solutions and further made acquisitions of a controlling stake of 51 in the erstwhile associate company TSA Process Equipments Private Limited by Thermax Limited. The StepDown Subsidiary FTS Cleanrooms Systems LLC acquired the business undertakings and ongoing projects of FTS Lifecare Technical Services LLC through a Business Transfer Agreement in May 2024.The Company is planning an IPO of 12060000 equity shares of Face Value of Rs 10/ each through Fresh Issue..

Revenue: ₹121.48Cr as on September 2025 (Q2 FY26)
Net Profit: ₹28.11Cr as on September 2025 (Q2 FY26)
Listing date: 07 Oct, 2025